139 related articles for article (PubMed ID: 12480690)
21. Arsenic trioxide and 2-methoxyestradiol reduce beta-catenin accumulation after proteasome inhibition and enhance the sensitivity of myeloma cells to Bortezomib.
Zhou L; Hou J; Fu W; Wang D; Yuan Z; Jiang H
Leuk Res; 2008 Nov; 32(11):1674-83. PubMed ID: 18485479
[TBL] [Abstract][Full Text] [Related]
22. Coordination of upregulated XBP-1 and downregulated c-myc during myeloma cell differentiation induced by 2-methoxyestradiol.
Zhou X; Jiang H; Hou J
Leuk Res; 2007 Sep; 31(9):1259-65. PubMed ID: 17257674
[TBL] [Abstract][Full Text] [Related]
23. Profiling of differential expression of messenger RNA in normal, benign, and metastatic prostate cell lines.
Chakrabarti R; Robles LD; Gibson J; Muroski M
Cancer Genet Cytogenet; 2002 Dec; 139(2):115-25. PubMed ID: 12550771
[TBL] [Abstract][Full Text] [Related]
24. 2-methoxyestradiol alters cell motility, migration, and adhesion.
Sattler M; Quinnan LR; Pride YB; Gramlich JL; Chu SC; Even GC; Kraeft SK; Chen LB; Salgia R
Blood; 2003 Jul; 102(1):289-96. PubMed ID: 12637335
[TBL] [Abstract][Full Text] [Related]
25. 2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF.
Mabjeesh NJ; Escuin D; LaVallee TM; Pribluda VS; Swartz GM; Johnson MS; Willard MT; Zhong H; Simons JW; Giannakakou P
Cancer Cell; 2003 Apr; 3(4):363-75. PubMed ID: 12726862
[TBL] [Abstract][Full Text] [Related]
26. Proteasome inhibitors disrupt the unfolded protein response in myeloma cells.
Lee AH; Iwakoshi NN; Anderson KC; Glimcher LH
Proc Natl Acad Sci U S A; 2003 Aug; 100(17):9946-51. PubMed ID: 12902539
[TBL] [Abstract][Full Text] [Related]
27. Expression and regulation of Cyr61 in human breast cancer cell lines.
Tsai MS; Bogart DF; Li P; Mehmi I; Lupu R
Oncogene; 2002 Jan; 21(6):964-73. PubMed ID: 11840342
[TBL] [Abstract][Full Text] [Related]
28. 2-methoxyestradiol up-regulates death receptor 5 and induces apoptosis through activation of the extrinsic pathway.
LaVallee TM; Zhan XH; Johnson MS; Herbstritt CJ; Swartz G; Williams MS; Hembrough WA; Green SJ; Pribluda VS
Cancer Res; 2003 Jan; 63(2):468-75. PubMed ID: 12543804
[TBL] [Abstract][Full Text] [Related]
29. 2-Methoxyestradiol confers neuroprotection and inhibits a maladaptive HIF-1α response after traumatic brain injury in mice.
Schaible EV; Windschügl J; Bobkiewicz W; Kaburov Y; Dangel L; Krämer T; Huang C; Sebastiani A; Luh C; Werner C; Engelhard K; Thal SC; Schäfer MK
J Neurochem; 2014 Jun; 129(6):940-54. PubMed ID: 24606183
[TBL] [Abstract][Full Text] [Related]
30. Activation of the endoplasmic reticulum stress pathway is associated with survival of myeloma cells.
Nakamura M; Gotoh T; Okuno Y; Tatetsu H; Sonoki T; Uneda S; Mori M; Mitsuya H; Hata H
Leuk Lymphoma; 2006 Mar; 47(3):531-9. PubMed ID: 16396777
[TBL] [Abstract][Full Text] [Related]
31. Altered mRNA expression of Pax5 and Blimp-1 in B cells in multiple myeloma.
Borson ND; Lacy MQ; Wettstein PJ
Blood; 2002 Dec; 100(13):4629-39. PubMed ID: 12453881
[TBL] [Abstract][Full Text] [Related]
32. Novel therapies targeting the myeloma cell and its bone marrow microenvironment.
Hideshima T; Chauhan D; Podar K; Schlossman RL; Richardson P; Anderson KC
Semin Oncol; 2001 Dec; 28(6):607-12. PubMed ID: 11740818
[TBL] [Abstract][Full Text] [Related]
33. Mechanism of action of 2-methoxyestradiol: new developments.
Mooberry SL
Drug Resist Updat; 2003 Dec; 6(6):355-61. PubMed ID: 14744499
[TBL] [Abstract][Full Text] [Related]
34. Gastrin induces over-expression of genes involved in human U373 glioblastoma cell migration.
Kucharczak J; Pannequin J; Camby I; Decaestecker C; Kiss R; Martinez J
Oncogene; 2001 Oct; 20(48):7021-8. PubMed ID: 11704826
[TBL] [Abstract][Full Text] [Related]
35. [Effect of 2-methoxyestradiol on differentiation of primary myeloma cells].
Gao WR; Hou J; Xiong H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Apr; 14(2):262-6. PubMed ID: 16638193
[TBL] [Abstract][Full Text] [Related]
36. Superoxide-dependent and -independent mitochondrial signaling during apoptosis in multiple myeloma cells.
Chauhan D; Li G; Sattler M; Podar K; Mitsiades C; Mitsiades N; Munshi N; Hideshima T; Anderson KC
Oncogene; 2003 Sep; 22(40):6296-300. PubMed ID: 13679868
[TBL] [Abstract][Full Text] [Related]
37. Hsp27 inhibits release of mitochondrial protein Smac in multiple myeloma cells and confers dexamethasone resistance.
Chauhan D; Li G; Hideshima T; Podar K; Mitsiades C; Mitsiades N; Catley L; Tai YT; Hayashi T; Shringarpure R; Burger R; Munshi N; Ohtake Y; Saxena S; Anderson KC
Blood; 2003 Nov; 102(9):3379-86. PubMed ID: 12855565
[TBL] [Abstract][Full Text] [Related]
38. Identification of okadaic-acid-induced genes by mRNA differential display in glioma cells.
Chin LS; Singh SK; Wang Q; Murray SF
J Biomed Sci; 2000; 7(2):152-9. PubMed ID: 10754390
[TBL] [Abstract][Full Text] [Related]
39. Blockade of ubiquitin-conjugating enzyme CDC34 enhances anti-myeloma activity of Bortezomib/Proteasome inhibitor PS-341.
Chauhan D; Li G; Hideshima T; Podar K; Shringarpure R; Mitsiades C; Munshi N; Yew PR; Anderson KC
Oncogene; 2004 Apr; 23(20):3597-602. PubMed ID: 15094775
[TBL] [Abstract][Full Text] [Related]
40. Molecular sequelae of proteasome inhibition in human multiple myeloma cells.
Mitsiades N; Mitsiades CS; Poulaki V; Chauhan D; Fanourakis G; Gu X; Bailey C; Joseph M; Libermann TA; Treon SP; Munshi NC; Richardson PG; Hideshima T; Anderson KC
Proc Natl Acad Sci U S A; 2002 Oct; 99(22):14374-9. PubMed ID: 12391322
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
